111 related articles for article (PubMed ID: 36075470)
1. Lycopene ameliorates hyperlipidemia via potentiation of AMP-activated protein kinase and inhibition of ATP-citrate lyase in diabetic hyperlipidemic rat model.
Elseweidy MM; Elawady AS; Sobh MS; Elnagar GM
Life Sci; 2022 Nov; 308():120934. PubMed ID: 36075470
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase.
Elseweidy MM; Elesawy AE; Sobh MS; Elnagar GM
Life Sci; 2022 Sep; 305():120751. PubMed ID: 35780841
[TBL] [Abstract][Full Text] [Related]
3. Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats.
Elseweidy MM; Zein N; Aldhamy SE; Elsawy MM; Saeid SA
Exp Biol Med (Maywood); 2016 Nov; 241(17):1943-1949. PubMed ID: 27460718
[TBL] [Abstract][Full Text] [Related]
4. Potential of Caffeic Acid and 10-Dehydrogingerdione as Lipid Regulators Relevant to Their Inhibitory Effect on miR-122 and ATP Citrate Lyase Activity in Diabetic Hyperlipidemic Rats.
Elseweidy MM; Elawady AS; Sobh MS; Alqhtani AH; Al-Gabri NA; Elnagar GM
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979705
[TBL] [Abstract][Full Text] [Related]
5. Losartan and azelastine either alone or in combination as modulators for endothelial dysfunction and platelets activation in diabetic hyperlipidemic rats.
Elseweidy MM; Elnagar GM; M Elsawy M; Ali AA; Zein N
J Pharm Pharmacol; 2020 Dec; 72(12):1812-1821. PubMed ID: 32880967
[TBL] [Abstract][Full Text] [Related]
6. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective.
Granchi C
Expert Opin Ther Pat; 2022 Jul; 32(7):731-742. PubMed ID: 35436171
[TBL] [Abstract][Full Text] [Related]
7. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
8. Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.
Nie XQ; Chen HH; Zhang JY; Zhang YJ; Yang JW; Pan HJ; Song WX; Murad F; He YQ; Bian K
Acta Pharmacol Sin; 2016 Apr; 37(4):483-96. PubMed ID: 26972495
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme A is required for rat liver fatty acid synthetase activity.
Linn TC; Stark MJ; Srere PA
J Biol Chem; 1980 Feb; 255(4):1388-92. PubMed ID: 7354035
[TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
11. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.
Verberk SGS; Kuiper KL; Lauterbach MA; Latz E; Van den Bossche J
Trends Mol Med; 2021 Dec; 27(12):1095-1105. PubMed ID: 34635427
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
Pinkosky SL; Filippov S; Srivastava RA; Hanselman JC; Bradshaw CD; Hurley TR; Cramer CT; Spahr MA; Brant AF; Houghton JL; Baker C; Naples M; Adeli K; Newton RS
J Lipid Res; 2013 Jan; 54(1):134-51. PubMed ID: 23118444
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of multiple neurotransmitters in the effects of Lycopene on brain injury induced by Hyperlipidemia.
Yang W; Shen Z; Wen S; Wang W; Hu M
Lipids Health Dis; 2018 Feb; 17(1):13. PubMed ID: 29409499
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers.
Shafik NM; Baalash A; Ebeid AM
Biol Trace Elem Res; 2017 Dec; 180(2):255-264. PubMed ID: 28409410
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
Ji G; Zhao X; Leng L; Liu P; Jiang Z
Lipids Health Dis; 2011 Jan; 10():23. PubMed ID: 21269482
[TBL] [Abstract][Full Text] [Related]
16. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Kuo YH; Lin CH; Shih CC
J Agric Food Chem; 2015 Nov; 63(46):10140-51. PubMed ID: 26503742
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Yang SJ; Je Lee W; Kim EA; Dal Nam K; Hahn HG; Young Choi S; Cho SW
Eur J Pharmacol; 2014 Aug; 736():26-34. PubMed ID: 24797782
[TBL] [Abstract][Full Text] [Related]
19. ε-Viniferin, a promising natural oligostilbene, ameliorates hyperglycemia and hyperlipidemia by activating AMPK
Liu R; Zhang Y; Yao X; Wu Q; Wei M; Yan Z
Food Funct; 2020 Nov; 11(11):10084-10093. PubMed ID: 33140813
[TBL] [Abstract][Full Text] [Related]
20. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
Maheshwari RA; Balaraman R; Sen AK; Seth AK
Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
